Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TESTING: Methylprednisolone for IgA Nephropathy
NCT01560052Phase 3Completed
- Sponsor
- The George Institute for Global Health
- Start
- May 2012
- Primary completion
- Jul 2021
- Countries
- 6
01
Overview
A Phase 3 trial of methylprednisolone in IgA nephropathy (IgAN), sponsored by The George Institute for Global Health. Started May 2012; status: completed.
02
Drugs
methylprednisolone
03
Conditions
IgA nephropathy (IgAN)
Beyond the preview
Go deeper on NCT01560052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01560052.